Vladimir T Valuev-Elliston

24PUBLICATIONS
57CO-AUTHORS
Preventative health careMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 27, 2026
Immunogenicity of a Candidate Hepatitis C Vaccine Based on Non-Structural DNA-Protein Sequences and a Novel Complex Adjuvant.

|Jan 22, 2026
CRISPR-Cas genome editing system in the diagnosis and therapy of infection caused by herpes simplex virus type 1 (Orthoherpesviridae: Alphaherpesviridae: Simplexvirus: Simplexvirus humanalpha1).

N A Demidova, R R Klimova, A A Kushch

|Nov 25, 2025
[Resistance and chemosensitivity restoration in human cytomegalovirus-infected tumor cells to doxorubicin through combined treatment with aqueous fullerene dC60].

Y Y Chernoryzh, K I Yurlov, T V Grebennikova

|Nov 13, 2025
Sumac Polyphenols as Pan-Herpesvirus Inhibitors.

Shavkat I Salikhov, Yuliya I Oshchepkova, Jamolitdin F Ziyavitdinov

|Oct 28, 2025
Occult hepatitis B: prevalence and clinical significance. Role in liver pathology and in viral coinfections.

A A Kushch

|Nov 27, 2024
Control of HSV-1 Infection: Directions for the Development of CRISPR/Cas-Based Therapeutics and Diagnostics.

Anastasiia O Sosnovtseva, Natalia A Demidova, Regina R Klimova

Pageof 4

Frequent Collaborators

13 joint publications

Regina R Klimova

12 joint publications

Olga V Masalova

10 joint publications

Natalya A Demidova

10 joint publications

Ekaterina I Lesnova